CAXTON ASSOCIATES LP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2021$99,000
-75.2%
35,916
-46.0%
0.01%
-77.3%
Q3 2021$399,000
+232.5%
66,569
+169.8%
0.04%
+238.5%
Q2 2021$120,00024,6770.01%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders